Media
1 item
Description
Global Pharmacological Drug Classification — FDA, EMA, PMDA, NMPA. Browse by category, subclass, or search by drug name/synonym. JP'S CLASSIFICATION OF DRUGS — GLOBAL PHARMACOLOGICAL REFERENCE A structured, offline drug classification reference covering 1,420+ drugs across 19 pharmacological chapters. Built for pharmacovigilance professionals, medical officers, pharmacists, clinicians, and students who need rapid, reliable access to drug classification data without opening a textbook or waiting for a website to load. ──────────────────────────────────────── WHAT IT COVERS ──────────────────────────────────────── 19 chapters organised by pharmacological mechanism, not by trade name or therapeutic area: 1. Autonomic Nervous System Pharmacology 2. Autacoids, Eicosanoids & Anti-inflammatory Agents 3. Respiratory Pharmacology 4. Endocrine Pharmacology & Hormonal Agents 5. Peripheral Nervous System & Neuromuscular Pharmacology 6. Central Nervous System Pharmacology 7. Cardiovascular Pharmacology 8. Renal Pharmacology 9. Haematological Pharmacology 10. Gastrointestinal Pharmacology 11. Antibacterial Agents 12. Antimicrobial Agents (Antifungal, Antiviral, Antiprotozoal, Anthelmintic) 13. Oncology Pharmacology — Anticancer & Antineoplastic Agents 14. Immunopharmacology — Immunosuppressants, Biologics & JAK Inhibitors 15. Dermatological Pharmacology 16. Ophthalmic Pharmacology 17. Rare Disease Therapeutics & Orphan Drug Pharmacology 18. Anaesthetic Pharmacology & Sedation Agents 19. Miscellaneous Pharmacological Agents ──────────────────────────────────────── REGULATORY COVERAGE ──────────────────────────────────────── Drugs approved by major global regulatory authorities are included: • US FDA — including novel targeted therapies, immune checkpoint inhibitors, antibody-drug conjugates, RNA-based drugs, gene therapies • EMA (European Medicines Agency) — including EU-specific approvals and European INN conventions • Japan PMDA — including Japan-approved agents where data is available • China NMPA — including domestically approved oncology and metabolic drugs ──────────────────────────────────────── WHAT YOU SEE FOR EACH DRUG ──────────────────────────────────────── • International Nonproprietary Name (INN) • General synonyms and common brand names • Dosing information (where confirmed from regulatory sources) • Classification path (chapter → subclass → subgroup) • All terms are searchable ──────────────────────────────────────── HOW TO USE IT ──────────────────────────────────────── SEARCH — Type any drug name, INN, synonym, brand name, or drug class into the search box. Results appear instantly. Click any result to navigate directly to that drug's classification page. BROWSE — Use the chapter dropdown to select a pharmacological system. An overview of all subclasses appears with clickable chips. Select any subclass from the second dropdown — or click directly on a chip — to see the full classification tree with all drugs listed. EXPAND — Click any drug entry to expand and see its dose, synonyms, and brand names. Click the subgroup header bar to collapse or expand the whole subgroup. ──────────────────────────────────────── WHO IT IS FOR ──────────────────────────────────────── • Pharmacovigilance officers and safety physicians — rapid drug identification and class verification for ICSR coding and signal detection • Medical affairs and regulatory professionals — cross-referencing drug classification for PSUR, PBRER, and RMP documents • Clinicians and prescribers — quick pharmacological mechanism and dose confirmation • Pharmacists — class verification and synonym lookup • Medical students and postgraduates — systematic pharmacology revision by mechanism ──────────────────────────────────────── WHAT MAKES IT DIFFERENT ──────────────────────────────────────── Most drug reference tools are organised by indication or therapeutic area. This tool follows the pharmacological classification system — organised by mechanism of action, receptor target, and chemical class — which is how pharmacologists, pharmacovigilance professionals, and medical educators think about drugs. • Mechanism-based, not indication-based • Covers modern drug classes often missing from textbook-era tools: SGLT-2 inhibitors, GLP-1/GIP dual agonists, anti-PD-1/PD-L1 immune checkpoint inhibitors, PARP inhibitors, CDK4/6 inhibitors, BTK inhibitors, siRNA drugs, CAR-T therapies, CFTR modulators, and more • Includes biologics, monoclonal antibodies, and antibody-drug conjugates • Covers rare disease orphan drugs and enzyme replacement therapies • HIV antiretroviral classification with fixed-dose combination regimens • Direct-acting antiviral HCV classification including pangenotypic regimens ──────────────────────────────────────── PRIVACY ──────────────────────────────────────── No data collection. No tracking. No analytics. No external servers. No login required. All drug data is bundled with the extension and read locally. The extension makes no network requests. It cannot read the pages you visit and requests no host permissions. ──────────────────────────────────────── IMPORTANT NOTICE ──────────────────────────────────────── This extension is a pharmacological reference and educational tool only. It is not a clinical decision support system and does not constitute medical or regulatory advice. Dosing information is indicative and sourced from published regulatory documents; always verify against current prescribing information before clinical use. Drug approvals and classifications change — always confirm against the current regulatory authority guidance for your jurisdiction. ──────────────────────────────────────── DEVELOPED BY ──────────────────────────────────────── Jayaprakash Lokhande https://www.linkedin.com/in/jayaprakash0011/